This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Zhou, J. Articles by Joshi, H. C. Search for Related Content PubMed PubMed Citation Articles by Zhou, J. Articles by Joshi, H. C.

Reversal of P-glycoprotein–Mediated Multidrug Resistance in Cancer Cells by the c-Jun NH₂-Terminal Kinase

¹ Department of Genetics and Cell Biology, College of Life Sciences, Nankai University, Tianjin, China; ² Department of Cell Biology, Emory University School of Medicine, Atlanta, Georgia; ³ BR Ambedkar Center for Biomedical Research, University of Delhi, Delhi, India; and ⁴ Institute of Pathology, Humboldt University Berlin, Charite Campus Mitte, Schumannstrasse, Berlin, Germany

Requests for reprints: Jun Zhou, Department of Genetics and Cell Biology, College of Life Sciences, Nankai University, Tianjin 300071, China. Phone: 86-22-2350-8800; Fax: 86-22-2350-8800; E-mail: junzhou{at}nankai.edu.cn.

A significant impediment to the success of cancer chemotherapy is multidrug resistance (MDR). A typical form of MDR is attributable to the overexpression of membrane transport proteins, such as P-glycoprotein, resulting in an increased drug efflux. In this study, we show that adenovirus-mediated enhancement of the c-Jun NH₂-terminal kinase (JNK) reduces the level of P-glycoprotein in a dose- and time-dependent manner. Protein turnover assay shows that the decrease of P-glycoprotein is independent of its protein stability. Instead, this occurs primarily at the mRNA level, as revealed by reverse transcription-PCR analysis. We find that P-glycoprotein down-regulation requires the catalytic activity of JNK and is mediated by the c-Jun transcription factor, as either pharmacologic inhibition of JNK activity or dominant-negative suppression of c-Jun remarkably abolishes the ability of JNK to down-regulate P-glycoprotein. In addition, electrophoretic mobility shift assay reveals that adenoviral JNK increases the activator protein binding activity of the mdr1 gene in the MDR cells. We further show that the decrease of P-glycoprotein level is associated with a significant increase in intracellular drug accumulation and dramatically enhances the sensitivity of MDR cancer cells to chemotherapeutic agents. Our study provides the first direct evidence that enhancement of the JNK pathway down-regulates P-glycoprotein and reverses P-glycoprotein–mediated MDR in cancer cells. (Cancer Res 2006; 66(1): 445-52)

This article has been cited by other articles:

				C.-Y. Han, K.-B. Cho, H.-S. Choi, H.-K. Han, and K.-W. Kang Role of FoxO1 activation in MDR1 expression in adriamycin-resistant breast cancer cells Carcinogenesis, September 1, 2008; 29(9): 1837 - 1844. [Abstract] [Full Text] [PDF]

				C. Xuan, W. Qiao, J. Gao, M. Liu, X. Zhang, Y. Cao, Q. Chen, Y. Geng, and J. Zhou Regulation of Microtubule Assembly and Stability by the Transactivator of Transcription Protein of Jembrana Disease Virus J. Biol. Chem., September 28, 2007; 282(39): 28800 - 28806. [Abstract] [Full Text] [PDF]

				K. Katayama, S. Yoshioka, S. Tsukahara, J. Mitsuhashi, and Y. Sugimoto Inhibition of the mitogen-activated protein kinase pathway results in the down-regulation of P-glycoprotein Mol. Cancer Ther., July 1, 2007; 6(7): 2092 - 2102. [Abstract] [Full Text] [PDF]

				M. Liu, D. Li, R. Aneja, H. C. Joshi, S. Xie, C. Zhang, and J. Zhou PO2-dependent Differential Regulation of Multidrug Resistance 1 Gene Expression by the c-Jun NH2-terminal Kinase Pathway J. Biol. Chem., June 15, 2007; 282(24): 17581 - 17586. [Abstract] [Full Text] [PDF]

				M. Liu, R. Aneja, C. Liu, L. Sun, J. Gao, H. Wang, J.-T. Dong, V. Sarli, A. Giannis, H. C. Joshi, et al. Inhibition of the Mitotic Kinesin Eg5 Up-regulates Hsp70 through the Phosphatidylinositol 3-Kinase/Akt Pathway in Multiple Myeloma Cells J. Biol. Chem., June 30, 2006; 281(26): 18090 - 18097. [Abstract] [Full Text] [PDF]